OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Isoquinoline alkaloids from the roots of Zanthoxylum rigidum as multi-target inhibitors of cholinesterase, monoamine oxidase A and Aβ1-42 aggregation
Erika Plazas, Stefanie Hagenow, Mónica Constanza Ávila Murillo, et al.
Bioorganic Chemistry (2020) Vol. 98, pp. 103722-103722
Closed Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine
Sneha Singh, Nandini Pathak, Eram Fatima, et al.
European Journal of Medicinal Chemistry (2021) Vol. 226, pp. 113839-113839
Closed Access | Times Cited: 139

Natural isoquinoline alkaloids: Pharmacological features and multi-target potential for complex diseases
Erika Plazas, Mónica C. Avila M, Diego Ricardo Muñoz-Cendales, et al.
Pharmacological Research (2022) Vol. 177, pp. 106126-106126
Closed Access | Times Cited: 90

New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer’s disease
Feng Zhang, Rujia Zhong, Cheng Cheng, et al.
Acta Pharmacologica Sinica (2020) Vol. 42, Iss. 9, pp. 1382-1389
Open Access | Times Cited: 74

Potential Therapeutic Applications of Plant-Derived Alkaloids against Inflammatory and Neurodegenerative Diseases
Babita Aryal, Bimal Kumar Raut, Salyan Bhattarai, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-18
Open Access | Times Cited: 49

Natural Products Inhibitors of Monoamine Oxidases—Potential New Drug Leads for Neuroprotection, Neurological Disorders, and Neuroblastoma
Narayan D. Chaurasiya, Francisco León, Ilias Muhammad, et al.
Molecules (2022) Vol. 27, Iss. 13, pp. 4297-4297
Open Access | Times Cited: 46

Natural Alkaloids as Multi-Target Compounds towards Factors Implicated in Alzheimer’s Disease
Rudolf Vrabec, Gerald Blunden, Lucie Cahlíková
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4399-4399
Open Access | Times Cited: 25

Biologically active isoquinoline alkaloids covering 2019–2022
Dengtuo Wang, Lulu Qin, Chen-Xin Jing, et al.
Bioorganic Chemistry (2024) Vol. 145, pp. 107252-107252
Open Access | Times Cited: 10

Potential of Naturally Derived Alkaloids as Multi-Targeted Therapeutic Agents for Neurodegenerative Diseases
Yew Rong Kong, Kai Ching Tay, Yi Xiang Su, et al.
Molecules (2021) Vol. 26, Iss. 3, pp. 728-728
Open Access | Times Cited: 54

Innovative Therapeutic Strategies in Alzheimer’s Disease: A Synergistic Approach to Neurodegenerative Disorders
Sarfaraz K. Niazi, Matthias Magoola, Zamara Mariam
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 741-741
Open Access | Times Cited: 6

New trends in the practical use of isoquinoline alkaloids as potential drugs applicated in infectious and non-infectious diseases
Tomasz Tuzimski, Anna Petruczynik
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115704-115704
Open Access | Times Cited: 16

Unveiling Amaryllidaceae alkaloids: from biosynthesis to antiviral potential – a review
Thilina U. Jayawardena, Natacha Mérindol, Nuwan Sameera Liyanage, et al.
Natural Product Reports (2023) Vol. 41, Iss. 5, pp. 721-747
Open Access | Times Cited: 15

Ethnobotanical significance of medicinal plants: Beta‐amyloid and tau aggregation inhibitors against Alzheimer's disease
A. Anand Ganapathy, Vijayakumari M. Haripriya, Niyati Acharya, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 37, Iss. 6
Closed Access | Times Cited: 14

Illustrating the Effect of Small Molecules Derived from Natural Resources on Amyloid Peptides
Rituparna Roy, Sandip Paul
The Journal of Physical Chemistry B (2023) Vol. 127, Iss. 3, pp. 600-615
Closed Access | Times Cited: 13

Chemical profile of the roots of Clausena lansium and their inhibitory effects of the over-activation in BV-2 microglial cells
Yingjie Wang, Gang Chen, Di Zhou, et al.
Phytochemistry (2024) Vol. 220, pp. 114008-114008
Closed Access | Times Cited: 5

Monoamine oxidase and neurodegeneration: mechanisms, inhibitors and natural compounds for therapeutic intervention.
Chayan Banerjee, Debasmita Tripathy, Deepak Kumar, et al.
Neurochemistry International (2024) Vol. 179, pp. 105831-105831
Closed Access | Times Cited: 5

Exploration of Isoquinoline Alkaloids as Potential Inhibitors against Human Islet Amyloid Polypeptide
Yanan Wang, Ting Zheng, Yan Huo, et al.
ACS Chemical Neuroscience (2022) Vol. 13, Iss. 14, pp. 2164-2175
Closed Access | Times Cited: 20

Undescribed isoquinolines from Zanthoxylum nitidum and their antiproliferative effects against human cancer cell lines
Feng Qin, Cai Yi Wang, Chun‐Gu Wang, et al.
Phytochemistry (2022) Vol. 205, pp. 113476-113476
Closed Access | Times Cited: 19

Mechanisms of Plant Secondary Metabolites in Antitumor Activity: Insights into circRNA Modulation
Tatiane Roquete Amparo, Tamires Cunha Almeida, Lucas Resende Dutra Sousa, et al.
Reference series in phytochemistry (2025), pp. 1-28
Closed Access

Therapeutic potential and limitation of condensed and hydrolyzed tannins in Parkinson's disease
Ran Zhao, Nan Jia, Shuyang Wu, et al.
International Journal of Biological Macromolecules (2025), pp. 141814-141814
Closed Access

Mechanisms of Plant Secondary Metabolites in Antitumor Activity: Insights into circRNA Modulation
Tatiane Roquete Amparo, Tamires Cunha Almeida, Lucas Resende Dutra Sousa, et al.
Reference series in phytochemistry (2025), pp. 1003-1030
Closed Access

Research progress of plant‐derived natural alkaloids in central nervous system diseases
Qingqing Zhang, Qinghua Jiang, Kuiru Sa, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 4885-4907
Closed Access | Times Cited: 10

Phytomolecules as Alzheimer’s Therapeutics: A Comprehensive Review
Mohd Kamil Hussain, Mafaz Ahmad, Shahnaaz Khatoon, et al.
European Journal of Medicinal Chemistry (2025) Vol. 288, pp. 117401-117401
Closed Access

Inhibitory Effects of Alkaloids Against Enzymes Linked to Neurodegenerative Diseases
İlkay Erdoğan Orhan, Fatma Sezer Şenol
Springer eBooks (2025), pp. 1-21
Closed Access

Alkaloids as neuroprotectors: targeting signaling pathways in neurodegenerative diseases
Biswajit Kumar Utpal, Md. Al Amin, Mehrukh Zehravi, et al.
Molecular and Cellular Biochemistry (2025)
Closed Access

Page 1 - Next Page

Scroll to top